Adeno-associated virus vectors can be efficiently produced without helper virus

Gene Therapy

Volumn 5, Issue 7, 1998, Pages 938-945

  Matsushita, T ^a,b   Elliger, S ^a,c   Elliger, C ^a,d   Podsakoff, G ^a   Villarreal, L ^e   Kurtzman, G J ^a   Iwaki, Y ^b   Colosi, P ^a,f  

^a Avigen Inc   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d CALIFORNIA ACADEMY OF SCIENCES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f School of Medicine ^*  (United States)

Author keywords

AAV helper genes; AAV vector production; Adenovirus

Indexed keywords

ANTISERUM; GENE PRODUCT; HELICASE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; DNA FLANKING REGION; FEMALE; GENE CONSTRUCT; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HELPER VIRUS; MOUSE; NONHUMAN; PARTICLE SIZE; PLASMID; PRIORITY JOURNAL; RNA GENE; VIRUS CAPSID;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS; DNA VIRUSES; MIRIDAE;

EID: 0031875874     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300680     Document Type: Article

References (38)

1. Okada H et al. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Therapy 1996; 3: 957-964.
2. Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 5804-5809.
3. Snyder R et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
4. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996; 70: 8098-8108.
5. Kessler PD et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082-14087.
6. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
7. Xiao X et al. Adeno-associated virus (AAV) vector antisence gene transfer in vivo decreases GABA(A) alphal containing receptors and increases inferior collcular seizure sensitivity. Brain Res 1997; 756: 76-83.
8. Conrad CK et al. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Therapy 1996; 3: 658-668.
9. Podsakoff G et al. Single dose, long-term treatment of murine β-thalassemia following intramuscular injection of an AAV vector. (Submitted).
10. Jomary C et al. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Therapy 1997; 4: 683-690.
11. Atchinson R, Castro B, Hammon W. Adeno-associated defective virus particles. Science 1965; 194: 754-756.
12. Buller RML et al. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol 1981; 40: 241-247.
13. Schlehofer JR, Ehrbar M, zur Hausen H. Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovims. Virology 1986; 152: 110-117.
14. Ito M, Suzuki E. Adeno-associated satellite virus growth supported by a temperature-sensitive mutant of human adenovirus. J Gen Virol 1970; 9: 243-245.
15. Ishibashi M. The potentiation of type 1 adeno-associated virus by temperature-sensitive conditional-lethal mutants of CELO virus at the restrictive temperature. Virology 1971; 45: 317-320.
16. Myers MW et al. Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2. J Virol 1980; 35: 65-75.
17. Carter BJ et al. Properties of an adenovirus type 2 mutant, Ad2dI807, having a deletion near the right-hand genome terminus: failure to help AAV replication. Virology 1983; 126: 505-516.
18. Samulski RJ, Shenk T. Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs. J Virol 1988; 62: 206-210.
19. Laughlin CA, Jones N, Carter BJ. Effect of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus. J Virol 1982; 41: 868-876.
20. Jay FT, Laughlin CA, Carter BJ. Eukaryotic translational control: adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein. Proc Natl Acad Sci USA 1981; 78: 2927-2931.
21. Huang MM, Hearing P. Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J Virol 1989; 63: 2605-2615.
22. Janik JE, Huston MM, Rose JA. Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc Natl Acad Sci USA 1981; 78: 1925-1929.
23. Janik JE et al. Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. Virology 1989; 168: 320-329.
24. Wigler M et al. Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc Natl Acad Sci USA 1980; 77: 3567-3570.
25. Graham FL et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1997; 36: 59-72.
26. Virtanen A et al. mRNAs from human adenovirus 2 early region 4. J Virol 1984; 51: 822-831.
27. Pettersson U. Structural and nonstructural adenovirus proteins. In: Ginsberg H (ed). The Adenoviruses. Plenum Press: New York, 1984, pp 205-270. Fraenkel-Conrat H, Wagner R (eds). The Viruses.
28. Thimmappaya B et al. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 1982; 31: 543-551.
29. Kitajewski J et al. Adenovirus VAI antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 1986; 45: 195-200.
30. West MH et al. Gene expression in adeno-associated virus vectors: the effects of chimeric mRNA structure, helper virus, and adenovirus VA1 RNA. Virology 1987; 160: 38-47.
31. Sarnow P et al. Adenovirus E1B-55K tumor antigen is physically associated with an E4-25K protein in productively infected cells. J Virol 1984; 49: 692-700.
32. Cutt JR, Shenk T, Hearing P. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J Virol 1987; 61: 543-552.
33. Leppard KN, Shenk T. The adenovirus E1B 55 kd protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO 1989; 8: 2329-2336.
34. Moore M, Horikoshi N, Shenk T. Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci USA 1996; 93: 11295-11301.
35. Neale GA, Kitchingman GR. Biochemical analysis of adenovirus type 5 DNA-binding protein mutants. J Biol Chem 1989; 264: 3153-3159.
36. Neale GA, Kitchingman GR. Conserved region 3 of the adenovirus type 5 DNA-binding protein is important for interaction with single-stranded DNA. J Virol 1990; 64: 630-638.
37. Carter BJ, Antoni BA, Kiessig DF. Adenovirus containing a deletion of the early region 2A gene allows growth of adeno-associated virus with decreased efficiency. Virology 1992; 191: 473-476.
38. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 1988; 163: 614-617.